Clinical Trial Update: A Pilot Study to Explore the Role of Gut Flora in Fatty Liver

View source ↗

Summary

A pilot trial exploring the role of gut microbiota in fatty liver has been withdrawn. The study identifier is NCT04160949 and sponsor is ProgenaBiome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fatty Liver Disease

Snippet

Sponsor: ProgenaBiome | Conditions: Fatty Liver | Status: WITHDRAWN